MET
74
2
HOG
47
4
DNB
62
12
TAP
63
3
EMC
42
3
PFG
52
13
AMZN
55
5
CRM
40
3
PG
61
-2
AXP
63
3
WYNN
36
4
AIV
43
2
PNW
67
-3
URBN
56
5
SWK
39
-3
PPG
44
3
TEL
65
4
PRU
64
4
PH
70
4
MAT
55
4
MET
74
2
HOG
47
4
DNB
62
12
TAP
63
3
EMC
42
3
PFG
52
13
AMZN
55
5
CRM
40
3
PG
61
-2
AXP
63
3
WYNN
36
4
AIV
43
2
PNW
67
-3
URBN
56
5
SWK
39
-3
PPG
44
3
TEL
65
4
PRU
64
4
PH
70
4
MAT
55
4
Financhill
Back

Seritage Growth Properties Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
24

SRG
Seritage Growth Properties

Last Price:
$3.31
Seasonality Move:
-1.12%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$73.63
Seasonality Move:
14.66%
Sell
24
Seritage Growth Properties (SRG) is a Sell

Is Seritage Growth Properties a Buy, Sell or Hold?

  • The current Seritage Growth Properties [SRG] share price is $3.43. The Score for SRG is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • SRG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRG Stock Price Chart

What is Seritage Growth Properties's stock price today?

  • The Seritage Growth Properties share price today is $3.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRG is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $76.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 45.91 Sell
Chaikin Money Flow: 147679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 3.75) Sell
Bollinger Bands (100): (3.61 - 4.31) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.07 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 1304026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.54 - 110.54) Sell
Bollinger Bands (100): (102.23 - 127.85) Sell

SRG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.41 Buy
20-day SMA: 3.49 Sell
50-day SMA: 3.67 Sell
200-day SMA: 4.32 Sell
8-day EMA: 3.41 Buy
20-day EMA: 3.49 Sell
50-day EMA: 3.67 Sell
200-day EMA: 4.71 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.29 Sell
20-day SMA: 96.26 Sell
50-day SMA: 107.61 Sell
200-day SMA: 124.92 Sell
8-day EMA: 82.75 Sell
20-day EMA: 92.99 Sell
50-day EMA: 104.03 Sell
200-day EMA: 117.97 Sell

Seritage Growth Properties Earnings Growth & SRG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Seritage Growth Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):